Case report. Hepatic abscesses due to Aspergillus terreus in an immunodeficient child.
We report the first case of hepatitis due to Aspergillus terreus in a 13-year-old boy with common variable immunodeficiency that occurred while the patient was receiving secondary prophylaxis with fluconazole after an episode of pulmonary candidosis. The infection subsided after the addition of itraconazole to the combination of liposomal amphotericin B and granulocyte-macrophage colony-stimulating factor that he was receiving.
Trachana
M
M
Roilides
E
E
Gompakis
N
N
Kanellopoulou
K
K
Mpantouraki
M
M
Kanakoudi-Tsakalidou
F
F
D000293:Adolescent; D000666:Amphotericin B / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use; D001228:Aspergillosis / Q000188:drug therapy / Q000382:microbiology*; D002175:Candida; D002177:Candidiasis / Q000517:prevention & control; D004359:Drug Therapy, Combination; D015725:Fluconazole / Q000008:administration & dosage / Q000627:therapeutic use; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000627:therapeutic use; D006801:Humans; D016867:Immunocompromised Host; D017964:Itraconazole / Q000627:therapeutic use; D008081:Liposomes; D008100:Liver Abscess / Q000188:drug therapy / Q000382:microbiology*; D008171:Lung Diseases / Q000517:prevention & control; D008297:Male; D016896:Treatment Outcome
D000935:Antifungal Agents; D008081:Liposomes; D017964:Itraconazole; D000666:Amphotericin B; D016178:Granulocyte-Macrophage Colony-Stimulating Factor; D015725:Fluconazole